1. Home
  2. NAII vs IRIX Comparison

NAII vs IRIX Comparison

Compare NAII & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Alternatives International Inc.

NAII

Natural Alternatives International Inc.

N/A

Current Price

$1.17

Market Cap

15.8M

Sector

Health Care

ML Signal

N/A

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.83

Market Cap

15.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAII
IRIX
Founded
1980
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.8M
15.0M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
NAII
IRIX
Price
$1.17
$0.83
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
27.3K
★ 671.9K
Earning Date
11-11-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 51.85
EPS
N/A
★ N/A
Revenue
★ $132,437,000.00
$41,593,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.58
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 8.60
N/A
52 Week Low
$1.11
$0.61
52 Week High
$4.96
$1.65

Technical Indicators

Market Signals
Indicator
NAII
IRIX
Relative Strength Index (RSI) 19.21 57.20
Support Level N/A $0.64
Resistance Level $2.83 $1.00
Average True Range (ATR) 0.19 0.09
MACD -0.03 0.03
Stochastic Oscillator 7.26 48.12

Price Performance

Historical Comparison
NAII
IRIX

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: